Search - tctmd.com

Displaying 121 - 140 of 359

Sort: Relevancy | Date

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Conference News HRS 2022

Intensive BP Control May Stave Off LV Conduction Disease: SPRINT

Todd Neale

May 02, 2022

News Opinion CV Team Dispatch

May 2022 News Roundup

L.A. McKeown

May 01, 2022

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

News Daily News

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

April 26, 2022

News Daily News

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Michael O'Riordan

April 22, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

Financial Strain Ups Risk of Death After Acute MI in the Elderly

L.A. McKeown

February 25, 2022

News Daily News

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Michael O'Riordan

February 14, 2022

News Conference News ISC 2022

CHOICE: Intra-arterial tPA Enhances Benefit of Stroke Thrombectomy

Todd Neale

February 11, 2022

News Daily News

Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension

Yael L. Maxwell

February 09, 2022

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Caitlin E. Cox

January 10, 2022

News Daily News

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

Todd Neale

December 29, 2021

News Daily News

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Michael O'Riordan

December 23, 2021

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

Advertisement

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Dapagliflozin Boosts Health Status Across LVEF Range

Good News and Bad for High-Intensity Statin Use in ASCVD

Intensive BP Control May Stave Off LV Conduction Disease: SPRINT

May 2022 News Roundup

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Financial Strain Ups Risk of Death After Acute MI in the Elderly

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

CHOICE: Intra-arterial tPA Enhances Benefit of Stroke Thrombectomy

Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content